News
-
1,000 on UTI trial
Monday | Jul 31 2023FROM today the NSW government's $3 million prescribing trial, launched in May, has expanded from 94 to 1,000 pharmacies.
-
Call to bring forward the 8CPA heard
Monday | Jul 31 2023THE PSA23 conference was headlined by the Federal Health Minster Mark Butler who shared in his speech, "there have been strong arguments put to the Government around bringing forward the negotiations for the Eighth Community Pharmacy Agreement (8CPA)".
-
Hepa filters can work in bushfire season
Monday | Jul 31 2023PORTABLE air purifiers fitted with high-efficiency particulate air (HEPA) filters can substantially improve indoor air quality during bushfire events, according to new research from the national science agency, CSIRO.
-
-
PD breaking news – PSA23: Locum and Intern Pharmacist of the Year awarded
Saturday | Jul 29 2023Locum William Chan and Intern Grace Quach recognised for theircontributions The Pharmaceutical Society of Australia (PSA).
-
PSA23 ‘upward trajectory’ despite 60DD
Friday | Jul 28 2023PSA23 opened today with its National President Dr Fei Sim saying she has "genuine belief in the positive and upward trajectory of our pharmacy profession".
-
Safety data review is on
Friday | Jul 28 2023THE UK is reviewing the class of drugs that include Novo Nordisk's weight loss drugs Ozempic and Saxenda after "some patients reported suicidal or self-harming thoughts", two weeks after similar action by the European Union, Reuters has reported.
-
Ready to play a key role
Friday | Jul 28 2023PHARMACIST and herbalist Gerald Quigley, a speaker at the upcoming Australasian College of Nutritional and Environmental Medicine (ACNEM) Annual Conference 2023, will be discussing how "pharmacy teams in all settings can play an important role in the support of Long COVID patients".
-
Time to capitalise
Friday | Jul 28 2023THE Dermal Therapy range has had a total brand growth in pharmacy of over 47%, with hair & scalp care seeing an 88.6% growth.
-
Galderma grows
Friday | Jul 28 2023FOLLOWING record growth in 2022, dermatology brand Galderma has reached the US$2 billion net sales mark in the first half of 2023, up 6.9% year-on-year, ahead of the company's expectations.
